A comparative study of the effects of venoms from five rear-fanged snake species on the growth of Leishmania major: Identification of a protein with inhibitory activity against the parasite

Toxicon

Volumn 58, Issue 1, 2011, Pages 28-34

  Peichoto, María E ^a,b   Tavares, Flávio L ^b   DeKrey, Gregory ^b   Mackessy, Stephen P ^b  

^a UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

^b UNIVERSITY OF NORTHERN COLORADO   (United States)

Author keywords

Antileishmanial activity; Hypsiglena torquata texana; Philodryas baroni; Philodryas olfersii olfersii; Philodryas patagoniensis; Phospholipase A2; Trimorphodon biscutatus lambda

Indexed keywords

AMPHOTERICIN B; HYPSIGLENA TORQUATA TEXANA VENOM; PHILODRYAS BARONI VENOM; PHILODRYAS OLFERSII OLFERSII VENOM; PHILODRYAS PATAGONIENSIS VENOM; PHOSPHOLIPASE A2; SNAKE VENOM; TRIMORPHIN; TRIMORPHODON BISCUTATUS LAMBDA VENOM; UNCLASSIFIED DRUG; VENOM;

ANTIPROTOZOAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; HYPSIGLENA TORQUATA TEXANA; IC 50; LEISHMANIA MAJOR; NONHUMAN; PHILODRYAS BARONI; PHILODRYAS OLFERSII OLFERSII; PHILODRYAS PATAGONIENSIS; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS; SNAKE; TRIMORPHODON BISCUTATUS LAMBDA;

ANIMALS; ANTIPARASITIC AGENTS; COLUBRIDAE; LEISHMANIA MAJOR; MASS SPECTROMETRY; SNAKE VENOMS;

HYPSIGLENA TORQUATA; LEISHMANIA MAJOR; PHILODRYAS BARONI; PHILODRYAS OLFERSII OLFERSII; PHILODRYAS PATAGONIENSIS; PROTOZOA; SERPENTES; TRIMORPHODON BISCUTATUS LAMBDA;

EID: 79959378157     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2011.04.018     Document Type: Article

References (38)

1. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
2. Calabrese E.J., Baldwin L.A. Hormesis: a generalizable and unifying hypothesis. Crit. Rev. Toxicol. 2001, 31:353-424.
3. Chen K.C., Kao P.H., Lin S.R., Chang L.S. p38 MAPK activation and mitochondrial depolarization mediate the cytotoxicity of Taiwan cobra phospholipase A2 on human neuroblastoma SK-N-SH cells. Toxicol. Lett. 2008, 180:53-58.
4. Conolly R.B., Lutz W.K. Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. Toxicol. Sci. 2004, 77:151-157.
5. Costa T.R., Menaldo D.L., Oliveira C.Z., Santos-Filho N.A., Teixeira S.S., Nomizo A., Fuly A.L., Monteiro M.C., de Souza B.M., Palma M.S., Stabeli R.G., Sampaio S.V., Soares A.M. Myotoxic phospholipases A2 isolated from Bothrops brazili snake venom and synthetic peptides derived from their C-terminal region: cytotoxic effect on microorganism and tumor cells. Peptides 2008, 29:1645-1656.
6. Desjeux P. Human leishmaniases: epidemiology and public health aspects. World Health Stat. Q. 1992, 45:267-275.
7. Doley R., Zhou X., Kini R.M. Snake venom phospholipase A2 enzymes. Handbook of Venoms and Toxins of Reptiles 2010, 173-205. CRC Press/Taylor & Francis Group, Boca Raton. S.P. Mackessy (Ed.).
8. Farooqui A.A., Horrocks L.A. Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei. Reprod. Nutr. Dev. 2005, 45:613-631.
9. Ferlan I., Ferlan A., King T., Russell F.E. Preliminary studies on the venom of the colubrid snake Rhabdophis subminatus (red-necked keelback). Toxicon 1983, 21:570-574.
10. Fernandez-Gomez R., Zerrouk H., Sebti F., Loyens M., Benslimane A., Ouaissi M.A. Growth inhibition of Trypanosoma cruzi and Leishmania donovani infantum by different snake venoms: preliminary identification of proteins from Cerastes cerastes venom which interact with the parasites. Toxicon 1994, 32:875-882.
11. Fry B.G., Scheib H., van der Weerd L., Young B., McNaughtan J., Ramjan S.F., Vidal N., Poelmann R.E., Norman J.A. Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia). Mol. Cell. Proteomics 2008, 7:215-246.
12. Gonçalves A.R., Soares M.J., Souza W.d., DaMatta R.A., Alves E.W. Ultrastructural alterations and growth inhibition of Trypanosoma cruzi and Leishmania major induced by Bothrops jararaca venom. Parasitol. Res. 2002, 88:598-602.
13. Hill R.E., Mackessy S.P. Venom yields from several species of colubrid snakes and differential effects of ketamine. Toxicon 1997, 35:671-678.
14. Holzer M., Mackessy S.P. An aqueous endpoint assay of snake venom phospholipase A2. Toxicon 1996, 34:1149-1155.
15. Huang P., Mackessy S.P. Biochemical characterization of phospholipase A2 (trimorphin) from the venom of the Sonoran Lyre Snake Trimorphodon biscutatus lambda (family Colubridae). Toxicon 2004, 44:27-36.
16. Kessentini-Zouari R., Jebali J., Taboubi S., Srairi-Abid N., Morjen M., Kallech-Ziri O., Bezzine S., Marvaldi J., El Ayeb M., Marrakchi N., Luis J. CC-PLA2-1 and CC-PLA2-2, two Cerastes cerastes venom-derived phospholipases A2, inhibit angiogenesis both in vitro and in vivo. Lab. Invest. 2010, 90:510-519.
17. Loiseau P.M., Bories C. Mechanisms of drug action and drug resistance in Leishmania as basis for therapeutic target identification and design of antileishmanial modulators. Curr. Top. Med. Chem. 2006, 6:539-550.
18. Ma A.D., Wu S.Y., Zhang J.J., Li Z.Q., Xu W., Wen X.Y., Yu L., Wu S.G. Purification of a new phospholipase A2 homologue from Agkistrodon blomhoffii siniticus and its effects on gene expression profile of Hep3B cells. Nan Fang Yi Ke Da Xue Xue Bao 2006, 26:75-79.
19. Mackessy S.P. Biochemistry and pharmacology of colubrid snake venoms. J. Toxicol. Toxin Rev. 2002, 21:43-83.
20. Mackessy S.P. The field of reptile toxinology. Snakes, lizards, and their venoms. Handbook of Venoms and Toxins of Reptiles 2010, 1-21. CRC Press/Taylor & Francis Group, Boca Raton. S.P. Mackessy (Ed.).
21. Mattson M.P. Hormesis defined. Ageing Res. Rev. 2008, 7:1-7.
22. Mora R., Valverde B., Diaz C., Lomonte B., Gutierrez J.M. A Lys49 phospholipase A2 homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line. Toxicon 2005, 45:651-660.
23. Mukherjee P., Majee S.B., Ghosh S., Hazra B. Apoptosis-like death in Leishmania donovani promastigotes induced by diospyrin and its ethanolamine derivative. Int. J. Antimicrob. Agents 2009, 34:596-601.
24. Passero L.F.D., Tomokane T.Y., Corbett C.E.P., Laurenti M.D., Toyama M.H. Comparative studies of the anti-leishmanial activity of three Crotalus durissus ssp. venoms. Parasitol. Res. 2007, 101:1365-1371.
25. Passero L.F., Laurenti M.D., Tomokane T.Y., Corbett C.E., Toyama M.H. The effect of phospholipase A2 from Crotalus durissus collilineatus on Leishmania amazonensis infection. Parasitol. Res. 2008, 102:1025-1033.
26. Peichoto M.E., Tavares F.L., Dekrey G., Mackessy S.P. Enzymatic and antileishmanial activities of five rear-fanged snake venoms. Toxicol. Lett. 2010, 196S:S347.
27. Rath S., Trivelin L.A., Imbrunito T.R., Tomazela D.M., Jesús M.N.d., Marzal P.C., Junior H.F.d.A., Tempone A.G. Antimoniais empregados no tratamento da leishmaniose: estado da arte. Quim. Nova 2003, 26:550-555.
28. Rosenberg H.I. An improved method for collecting secretion from Duvernoy's gland of colubrid snakes. Copeia 1992, 1992:244-246.
29. Rosenthal E., Delaunay P., Jeandel P.Y., Haas H., Pomares-Estran C., Marty P. Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe. Med. Mal. Infect. 2009, 39:741-744.
30. Rufini S., de Vito P., Balestro N., Pescatori M., Luly P., Incerpi S. PLA2 stimulation of Na(+)/H(+) antiport and proliferation in rat aortic smooth muscle cells. Am. J. Physiol. 1999, 277:C814-C822.
31. Sabina H., Tasneem S., Samreen Y., Kausar Choudhary M.I., Aliya R. Antileishmanial activity in the crude extract of various seaweed from the coast of Karachi, Pakistan. Pak J Bot. 2005, 37:163-168.
32. Sacks D.L., Perkins P.V. Identification of an infective stage of Leishmania promastigotes. Science 1984, 223:1417-1419.
33. Schaeffer E.L., Forlenza O.V., Gattaz W.F. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology (Berl) 2009, 202:37-51.
34. Soares A.M., Fontes M.R.M., Giglio J.R. Phospholipases A2 myotoxins from Bothrops snake venoms: structure-function relationship. Curr. Org. Chem. 2004, 8:1677-1690.
35. Stabeli R.G., Amui S.F., Sant'Ana C.D., Pires M.G., Nomizo A., Monteiro M.C., Romao P.R., Guerra-Sa R., Vieira C.A., Giglio J.R., Fontes M.R., Soares A.M. Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: an example of function versatility of snake venom proteins. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 2006, 142:371-381.
36. Tempone A.G., Andrade H.F., Spencer P.J., Lourenco C.O., Rogero J.R., Nascimento N. Bothrops moojeni venom kills Leishmania spp. with hydrogen peroxide generated by its L-amino acid oxidase. Biochem. Biophys. Res. Commun. 2001, 280:620-624.
37. Costa Torres A.F., Dantas R.T., Toyama M.H., Diz Filho E., Zara F.J., Rodrigues de Queiroz M.G., Pinto Nogueira N.A., Rosa de Oliveira M., de Oliveira Toyama D., Monteiro H.S., Martins A.M. Antibacterial and antiparasitic effects of Bothrops marajoensis venom and its fractions: phospholipase A2 and L-amino acid oxidase. Toxicon 2010, 55:795-804.
38. Weldon C.L., Mackessy S.P. Biological and proteomic analysis of venom from the Puerto Rican Racer (Alsophis portoricensis: Dipsadidae). Toxicon 2010, 55:558-569.